Laboratoire Francais Du Fractionnement Et Des Biotechnologies

Etat Francais Represente Par Le Directeur Central Du Service De Sante Des Armees

Denis Hoguet

Christian Behrens

Philippe Klein

The present invention relates to a class-G immunoglobulin against the anthrax toxin protective antigen (PA), or one of the fragments of same, comprising at least: a variable heavy-chain region comprising an amino acid sequence represented by the sequence SEQ ID NO: 1, or comprising an amino acid sequence having at least 90% identity with the sequence SEQ ID NO: 1, and comprising the amino acids Leucine in position 51 and Glycine in position 67, and a variable light-chain region comprising an amino acid sequence represented by the sequence SEQ ID NO: 2, or comprising an amino acid sequence having at least 90% identity with the sequence SEQ ID NO: 2, and comprising a Leucine amino acid in position 55. The invention also relates to the uses of such an immunoglobulin.

Growing community of inventors

Saint Hilaire de Brethmas, France

Denis Hoguet